FDA-cleared profile

SMART Bun-Yo-Matic CT

Disior Ltd · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.

Clinical role
CT-based three-dimensional measurement, visualization, and surgical-planning support.
Images and patients
CT/CTA · Foot/Ankle
Key limitation
Keep in mind: Outputs support professional planning and do not prescribe the surgical procedure; users must review measurements and apply clinical judgment.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Foot/Ankle Input: Eligible CT image series of the foot and ankle meeting labeled acquisition and quality requirements.
  • Who uses it?Intended users: Qualified orthopaedic professionals.
  • What does the software produce?Output: Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.
  • What is its most important limitation?Key limitation: Outputs support professional planning and do not prescribe the surgical procedure; users must review measurements and apply clinical judgment.

Clinical takeaway. Clinical role: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.

Evidence takeaway. Evidence from the reviewed source record: FDA-described testing used 82 CT image series. Foot and ankle bones were correctly identified in all test series; metal presence detection was reported with 100% sensitivity and 98% specificity. The summary states that component testing met the predetermined acceptance criteria and that clinical data were not needed for the substantial-equivalence determination.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
CT-based three-dimensional measurement, visualization, and surgical-planning support.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Eligible CT image series of the foot and ankle meeting labeled acquisition and quality requirements.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Orthopaedic clinical and preoperative-planning workflows.
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Qualified orthopaedic professionals.
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Outputs support professional planning and do not prescribe the surgical procedure; users must review measurements and apply clinical judgment.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
FDA-described testing used 82 CT image series. Foot and ankle bones were correctly identified in all test series; metal presence detection was reported with 100% sensitivity and 98% specificity. The summary states that component testing met the predetermined acceptance criteria and that clinical data were not needed for the substantial-equivalence determination.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-described testing used 82 CT image series. Foot and ankle bones were correctly identified in all test series; metal presence detection was reported with 100% sensitivity and 98% specificity. The summary states that component testing met the predetermined acceptance criteria and that clinical data were not needed for the substantial-equivalence determination.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
100% sensitivity for the metal-presence detection component; this is not patient-level disease-detection sensitivity.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported specificity
98% specificity for the metal-presence detection component; this is not patient-level disease-detection specificity.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Foot and ankle bone identification

100 percent

  • EndpointCT image series with correctly identified foot and ankle bones
  • PopulationCT component test set
  • Tested versionSMART Bun-Yo-Matic CT configuration submitted in K240642

Metal-presence detection sensitivity

100 percent

  • EndpointSensitivity for identifying metal presence in CT images
  • PopulationCT component test set
  • Tested versionSMART Bun-Yo-Matic CT configuration submitted in K240642

Metal-presence detection specificity

98 percent

  • EndpointSpecificity for identifying metal presence in CT images
  • PopulationCT component test set
  • Tested versionSMART Bun-Yo-Matic CT configuration submitted in K240642

SMART Bun-Yo-Matic CT component performance testing

  • DesignNonclinical component testing of bone identification, metal identification, segmentation, measurements, and surgical-planning calculations.
  • Population82 CT image series in the held-out component test set; the FDA summary states that clinical data were not required.
  • Scopeexact submission
  • Tested versionSMART Bun-Yo-Matic CT configuration submitted in K240642
  • Samplen=82
  • IndependenceSponsor or vendor study

K240642

FDA submission evidence; component metrics are not diagnostic accuracy for a disease endpoint.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K240642. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Eligible CT image series of the foot and ankle meeting labeled acquisition and quality requirements.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT

  2. Routing

    Source context, not route validation: The exact FDA summary establishes CT image-series processing and a software planning workflow; exact hosting and PACS or EHR interfaces require vendor confirmation.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT

  3. AI processing

    Source context, not route validation: The exact FDA package describes SMART Bun-Yo-Matic CT as having a graphical user interface (GUI) to a web application. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Interface (GUI) to a web application". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K240642: SMART Bun-Yo-Matic CT

  4. Returned objects

    Source context, not route validation: Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT

  5. Viewer/worklist/report

    Unresolved route: Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K240642: SMART Bun-Yo-Matic CT

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes SMART Bun-Yo-Matic CT as having a graphical user interface (GUI) to a web application. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Interface (GUI) to a web application". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact FDA summary establishes CT image-series processing and a software planning workflow; exact hosting and PACS or EHR interfaces require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-09-08

Current product-family workflow context

Paragon 28 publishes a current-family IFU describing foot and ankle measurement and surgical-planning workflows and their visualization-only boundaries.

product family · checked 2026-09-08

Confirm exact-release availability, interfaces, hosting, security, support, and commercial terms during procurement.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K240642
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Foot/Ankle
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-06-20
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor instructions for use, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K240642 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-08 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K240642: SMART Bun-Yo-Matic CT

    U.S. Food and Drug Administration - Published 2024-06-20 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. SMART Bun-Yo-Matic Xray 1.0 instructions for use

    Paragon 28 - Accessed 2026-09-08

    Scope: productFamily, clinicalWorkflow, implementationCapabilities, limitations

  7. openFDA exact recall query for K240642

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

Research history

  1. K240642 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K223757

Bonelogic

Disior Ltd

Authorized purpose: Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.

Modality
CT/CTA
Anatomy
Foot/ankle
Decision
2023-12-08
FDA-cleared K221432

Customize

3D-Side SA

Customize supports adult total ankle arthroplasty planning with CT segmentation, 3D models, implant positioning and sizing, plan review, and X-ray-informed planning.

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2022-08-03
FDA-cleared K260406

Brainomix 360 Hyperdensity

Brainomix Limited

Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.

Modality
CT/CTA
Anatomy
Brain
Decision
2026-06-12

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history